The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process.

Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”

The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

Target Disease Indication
• Breast Cancer
• Chronic Lymphocytic Leukemia
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Lupus Nephritis
• Melanoma
• Multiple Myeloma
• Primary Sjögren's Syndrome
• Others

Target Immune Checkpoint
• B7-H3
• CD38
• CD40
• CD47
• Others

Mechanism of Action
• Inhibitory
• Stimulatory

Therapeutic Modality
• Monoclonal Antibody
• Small Molecule

Type of Therapy
• Monotherapy
• Combination Therapy

Route of Administration
• Intravenous
• Subcutaneous
• Others

Key Geographical Regions
• North America
• Europe
• Asia-Pacific and the Rest of the World

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
• Advanced Accelerator Applications
• Belgian Nuclear Research Center (SCK•CEN)
• Cardinal Health
• China Isotope & Radiation Corporation
• Curium Pharma
• DuChemBio
• Eckert & Ziegler
• Eczacibasi-Monrol
• GE Healthcare
• Jubilant DraxImage
• Lantheus Medical Imaging
• Nihon Medi-Physics
• Nordion
• PETNET Solutions
• SinoTau Pharmaceuticals
• SOFIE

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape
6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America
7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe
8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis
10. Partnerships and Collaborations
11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)
12. Market Forecast and Opportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]